In 2023, the catheter-directed thrombolysis market is expected to be worth US$ 454.8 million. By 2033, the market is projected to develop at a CAGR of 5.9% and reach a value of US$ 808 million.
The widespread increase in many chronic diseases like obesity, cancer, kidney ailments, coronary heart disorders, etc., is one of the key factors propelling the growth of catheter-directed thrombolysis devices. Apart from this, the surging health awareness regarding early diagnosis and therapy for deep vein thrombosis disorders and pulmonary embolism is also fueling the market growth.
Our Sample Report for Key Insights Catheter-directed Thrombolysis Market! https://www.futuremarketinsights.com/reports/sample/rep-gb-5143
Multiplication of the elderly population, who are susceptible to severe medical conditions, is expected to bolster the requirement for minimal-invasive therapies requiring CDT devices. Moreover, surging investments by several government authorities in the healthcare sector, in addition to the surging consumer medical expenses, are also supporting market growth.
Continuous progress in CDT devices is lowering the risk associated with post-thrombotic syndrome (PTS) and offering high-quality patient care, thus boosting their uptake. Besides, numerous healthcare professionals are showing a preference for MI surgeries, which are a safer alternative than traditional open surgeries, thus acting as another growth propeller.
Over the forecast period, the advent of pharmacomechanical CDT (PCDT) techniques to reduce treatment time and related healthcare costs. This is expected to contribute toward market growth.
The market might be challenged by certain factors. The dearth of modern healthcare infrastructure in developing nations is expected to pose a major hindrance. Other than that, there is a low or absence of knowledge and associated risk with this procedure.
Top Highlights from the FMI’s Analysis of the Catheter-directed Thrombolysis Market:
- The North American catheter-directed thrombolysis industry is expected to gain 53.4% market share, with the United States enjoying the leading position in the region and globe by attaining 47% in the global market.
- Although Europe’s market share is less than half of North America’s, i.e., Europe garnered a 24.1% market share in 2022. The region still holds a prominent position in the market.
- Germany leads the European market with a market share of 4.7%.
- Japan has a value share of 3.1%, attracting businesses to delve deep into the market for revenue prospects.
- Australia’s growth rate in the market, as estimated by FMI, is expected to be 5.2% CAGR over the forecast period.
- China is expected to expand at a robust pace of 7.1% over the forecast period.
- India, another Asian country, is expected to expand at a CAGR of 5.8% from 2023 to 2033.
- The United Kingdom is expected to expand at a CAGR of 4.1% over the forecast period.
- Under the delivery mode category, direct delivery to the blood clot segment is expected to garner a market share of more than 62.8% over the forecast period.
- Based on end users, the hospital segment is expected to grab a value share of more than 47.8%.
Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-5143
Key Players in the News:
- In August 2022, Boston Scientific Corporation obtained Obsidio, Inc., which is a privately-owned firm that has created Gel Embolic Material (GEM) technology for the coagulum of blood vessels in the peripheral circulatory system.
- In July 2020, iVascular S.L.U introduced its sergeant peripheral support catheter for patients suffering from peripheral artery disorder or difficult anatomy during interventional and diagnostic procedures. The device delivers brilliant pushability and torque capacity due to its tapered shaft design.
Some of the key participants present in the market include:
- AngioDynamics Inc.
- Boston Scientific Corporation
- iVascular SLU
- Straub Medical AG
Customization Unleashed: Learn How to Stand Out in a Competitive Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-5143
Key Segments:
By Delivery Mode:
- Direct Delivery to Blood Clot Catheter-directed Thrombolysis
- Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site
By Indication:
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Strokes
- Other Indications
By End User:
- Hospitals
- Surgical Centers
- Radiology Clinics
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
- Europe
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
Neurovascular Devices / Interventional Neurology Market: https://www.futuremarketinsights.com/reports/neurovascular-devices-market
Knee Reconstruction Devices Market: https://www.futuremarketinsights.com/reports/knee-reconstruction-market
Progressive Pulmonary Fibrosis (PPF) Treatment Market: https://www.futuremarketinsights.com/reports/progressive-pulmonary-fibrosis-ppf-treatment-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube